ShareValue.ai

ShareValue scores for 000020.KO: Valuation 61, Quality 70, Growth 57, Health 44.

000020.KO
KRX

Dongwha Pharm.Co.Ltd

₩5,330.00(+0.38%)
Loading chart...
Sentiment

Verdicts

Rating

Trap Risk

Return

8% to 17%
Valuation
61
Fair Value
Price vs Value
Quality
70
Strong
Business Strength
Growth
57
Moderate
Revenue & Earnings
Health
44
Moderate
Financial Stability
Momentum
64
Bullish
Price Trend

Company Details

About

Dongwha Pharm.Co.,Ltd manufactures and sells pharmaceutical products in South Korea. It offers ethical products in the areas of alimentary system, antibiotic, cardiovascular/metabolic disease, NSAID/respiratory system, muscle relaxants/musculoskeletal system, nervous system, and dermatological/urinary system; OTC products in the areas of alimentary system, cold remedy, NSAID/respiratory system, dermatological, mouth and tooth, hepatic protectors, nutrients, tonics, topic analgesic, antihistamines, sore throat, and others; quasi drugs; health subsidiary foods; foods and drinks; and cosmetics. The company also exports its products. Dongwha Pharm.Co.,Ltd was founded in 1897 and is headquartered in Seoul, South Korea. Address: FastFive Tower, Seoul, South Korea, 04522

Score Analysis

AI Investment Thesis

Data as of:Jun 12, 2026
|
Last calculated:Jun 12, 2026